Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0869620200370030330
Journal of Korean Society of Hospital Pharmacists
2020 Volume.37 No. 3 p.330 ~ p.340
Clinical Efficacy and Safety of Sarpogrelate and Aspirin for Preventing Hepatic Artery Thrombosis After Liver Transplantation
Lee Eun-Bin

Kim Hyo-Jin
Kim Jae-Song
Son Eun-Sun
Yu Yun-Mi
Abstract
Background : Hepatic artery thrombosis (HAT) is one of the most serious complications that can occur after liver transplantation. It is a major cause of graft loss. The aim of this study was to analyze the efficacy and safety of sarpogrelate and aspirin for preventing HAT after liver transplantation.

Methods : Electronic medical records of patients who had undergone their first liver transplantation at a tertiary hospital in Korea between August 1, 2016 and July 31, 2018 and received sarpogrelate or aspirin for HAT prevention were retrospectively reviewed. Iincidence of HAT and vascular complications and incidence of major bleeding events were selected as indicators for efficacy and safety, respectively.

Results : A total of 114 patients were included in this study. The incidence rate of HAT in the group receiving sarpogrelate or aspirin was 2.1 or 1.5%, respectively (p=0.820). No significant difference was also found in the incidence rate of portal vein thrombosis (p=0.481) or hepatic vein thrombosis (p=0.508) between the two groups. Although bleeding events with a decrease in hemoglobin level ¡Ã 3 g/dL in the aspirin group were significantly higher than those in the sarpogrelate group (p=0.032), the incidence of major bleeding events was not statistically different between the two groups (p=0.127).
Conclusion : There was no statistically significant difference in HAT prevention or major bleeding events between sarpogrelate and aspirin groups. Future research is needed to establish guidelines for the use of antiplatelet agents to prevent HAT in liver transplant patients.
KEYWORD
Liver transplantation, Sarpogrelate, Aspirin, Hepatic artery thrombosis, Major bleeding
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)